These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3592562)

  • 1. The effects of glucose-containing solutions on ischemic myocardium.
    Wittnich C; Peniston C; Salerno TA
    Ann Chir Gynaecol; 1987; 76(1):77-83. PubMed ID: 3592562
    [No Abstract]   [Full Text] [Related]  

  • 2. Myocardial protection during ischemic cardiac arrest. Possible deleterious effects of glucose and mannitol in coronary infusates.
    Hearse DJ; Stewart DA; Braimbridge MV
    J Thorac Cardiovasc Surg; 1978 Jul; 76(1):16-23. PubMed ID: 661362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dr. Buckberg's solution is not the answer to the cardioplegia controversy.
    O'Neill MJ; Neely JR; Waldhausen JA
    J Thorac Cardiovasc Surg; 1980 Jun; 79(6):940-2. PubMed ID: 6990114
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of reperfusional damage from ischemic myocardium.
    Kao RL; Magovern GJ
    J Thorac Cardiovasc Surg; 1986 Jan; 91(1):106-14. PubMed ID: 3941553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial preservation during cardiopulmonary bypass: an overview.
    Maloney JV; Nelson RL
    J Thorac Cardiovasc Surg; 1975 Dec; 70(6):1040-50. PubMed ID: 1186282
    [No Abstract]   [Full Text] [Related]  

  • 6. [Protection of the ischemic myocardium in cardio-pulmonary bypass: Experience with cardioplegic Bretschneider solution (author's transl)].
    Milano S; Chiodera PL; Pardini S; Iosi G; Valenti F; Mombelloni G
    G Ital Cardiol; 1980; 10(8):1006-15. PubMed ID: 7461346
    [No Abstract]   [Full Text] [Related]  

  • 7. [Potassium and anti-ischemic protection of the myocardium].
    Dvortsin GF
    Patol Fiziol Eksp Ter; 1984; (4):86-90. PubMed ID: 6384898
    [No Abstract]   [Full Text] [Related]  

  • 8. [Metabolism and ultrastructure of the myocardium in protection of the heart against ischemia using an ozonized cardioplegic solution].
    Korolev BA; Boiarinov GA; Monakhov AN; Shvets NA; Peretiagin SP
    Grudn Khir; 1983; (6):27-31. PubMed ID: 6654158
    [No Abstract]   [Full Text] [Related]  

  • 9. Retroperfusion of the heart with a solution of glucose, insulin, and potassium during anoxic arrest.
    Lolley DM; Hewitt RL; Drapanas T
    J Thorac Cardiovasc Surg; 1974 Mar; 67(3):364-70. PubMed ID: 4813438
    [No Abstract]   [Full Text] [Related]  

  • 10. Glucose substrate in myocardial protection.
    Salerno TA; Wasan SM; Charrette EJ
    J Thorac Cardiovasc Surg; 1980 Jan; 79(1):59-62. PubMed ID: 7350389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial preservation. Open discussion.
    J Thorac Cardiovasc Surg; 1975 Dec; 70(6):1024-39. PubMed ID: 1186281
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of myocardial metabolism with microdialysis during bypass surgery with cold blood- or Calafiore cardioplegia.
    Pöling J; Rees W; Mantovani V; Klaus S; Bahlmann L; Ziaukas V; Hübner N; Warnecke H
    Eur J Cardiothorac Surg; 2006 Oct; 30(4):597-603. PubMed ID: 16901714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial energy replenishment and reversal of ischemic damage by substrate enhancement of secondary blood cardioplegia with amino acids during reperfusion.
    Lazar HL; Buckberg GD; Manganaro AM; Becker H
    J Thorac Cardiovasc Surg; 1980 Sep; 80(3):350-9. PubMed ID: 7412340
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of multidose cardioplegia and cardioplegic solution buffering on myocardial tissue acidosis.
    Tait GA; Booker PD; Wilson GJ; Coles JG; Steward DJ; MacGregor DC
    J Thorac Cardiovasc Surg; 1982 Jun; 83(6):824-9. PubMed ID: 6283276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism in non-ischemic myocardium during coronary artery occlusion and reperfusion.
    Buxton DB; Mody FV; Krivokapich J; Schelbert HR
    J Mol Cell Cardiol; 1993 Jun; 25(6):667-81. PubMed ID: 8411193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of crystalloid and sanguineous cardioplegic solutions in the dog.
    Spackman CJ; Caywood DD; Gannon PG; Irmiter RA; Louis CF
    Am J Vet Res; 1985 Jun; 46(6):1330-4. PubMed ID: 4026010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathogenesis of myocardial cell death.
    Brachfeld N
    Recent Adv Stud Cardiac Struct Metab; 1972; 1():59-70. PubMed ID: 4681486
    [No Abstract]   [Full Text] [Related]  

  • 18. Myocardial protection with pinacidil induced hyperpolarized arrest during cardiopulmonary bypass.
    Yu T; Yu Z; Liu X; Yang S; Ye Y
    Chin Med J (Engl); 2001 Dec; 114(12):1245-8. PubMed ID: 11793844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical importance of ensuring cardioplegic delivery with coronary stenoses.
    Becker H; Vinten-Johansen J; Buckberg GD; Follette DM; Robertson JM
    J Thorac Cardiovasc Surg; 1981 Apr; 81(4):507-15. PubMed ID: 7206757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of potentials in using fluorocarbon cardioplegia for protecting the myocardium against ischemia].
    Beloiartsev FF; Kaĭdash AN; Islamov BI; Maevskiĭ EI; Kokoz IuM
    Vestn Akad Med Nauk SSSR; 1986; (6):37-43. PubMed ID: 3751261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.